Geode Capital Management’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-935,633
Closed -$26.8M 4850
2022
Q4
$26.8M Buy
935,633
+92,941
+11% +$2.68M ﹤0.01% 1580
2022
Q3
$24.6M Buy
842,692
+374,539
+80% +$8.63M ﹤0.01% 1583
2022
Q2
$6.46M Buy
468,153
+18,258
+4% +$257K ﹤0.01% 2555
2022
Q1
$8.16M Buy
449,895
+27,846
+7% +$399K ﹤0.01% 2479
2021
Q4
$6M Buy
422,049
+8,380
+2% +$130K ﹤0.01% 2790
2021
Q3
$7.39M Buy
413,669
+142,951
+53% +$3.68M ﹤0.01% 2684
2021
Q2
$8.24M Buy
270,718
+7,088
+3% +$195K ﹤0.01% 2598
2021
Q1
$7.71M Buy
+263,630
New +$8.16M ﹤0.01% 2539

Other funds holding SGFY

Geode Capital Management's SGFY Position: Q1 2023 in Review

Geode Capital Management sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 935,633 shares — an estimated $26.8M sold.

Geode Capital Management first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $26.8M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Geode Capital Management reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 935,633 Signify Health, Inc. shares in Q1 2023, an estimated $26.8M.
  • Geode Capital Management first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
  • Geode Capital Management's Signify Health, Inc. position peaked at $26.8M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.